Washington, DC (PRWEB) April 17, 2012
Atlantic Information Services, Inc., publisher of Drug Benefit News and Specialty Pharmacy News, is pleased to announce its April 24 webinar, “The New Express Scripts: What Does the Largest PBM Acquisition in History Mean for Your Business?” See webinar details at http://aishealth.com/marketplace/c2p21_042412.
After an exhaustive review by the Federal Trade Commission over anticompetitive concerns, Express Scripts, Inc.’s $29.1 billion acquisition of Medco Health Solutions, Inc., was approved and closed on April 2, resulting in the creation of the largest PBM in history. The new Express Scripts will control more than 30% of the PBM market, and the company claims its increased buying power will further drive down its already competitive prices.
But while the merger was pending, it created enough anxiety among purchasers of drug benefits that smaller PBMs started getting invited to the table more often. With the “big three” PBMs now reduced to the big two, and other PBMs actively merging and acquiring to compete in that space, the PBM landscape is evolving like never before, and plan sponsors need to rethink their drug purchasing strategies going forward.
During the webinar a renowned industry analyst and a leading pharmacy benefits consultant will discuss the implications of this major acquisition for the entire health care industry. Participants will get reliable strategic information on key questions, such as:
- What will the new company look like? What kind of integration issues will it face?
- How will this historic combination impact the pharmaceutical supply chain and, ultimately, the plan sponsor?
- How will the merger alter the PBM landscape?
- How does this event compare to other major PBM mergers or acquisitions (such as the 2007 merger of CVS Corp. and Caremark Rx)? What were some lessons learned from these types of deals in the past?
- What are the implications for retail networks, given Express Scripts’ highly publicized dispute with Walgreen Co.?
- How will the deal affect the ability of health plans and employers to contract with PBMs?
- What are the implications for formulary strategies and rebate contracting?
- What are the implications for specialty pharmacy?
After a 60-minute presentation, a concluding 30-minute question-and-answer session will allow webinar participants to pose individual questions to the speakers. Visit http://aishealth.com/marketplace/c2p21_042412#speakers to learn more about them:
- Larry Marsh, a managing director at Barclays Capital, where he covers the health care distribution and technology industry, and most recently had served as the department’s healthcare services/med tech sector head.
- Josh Golden, a pharmacy benefit consultant at Pharmaceutical Strategies Group LLC with more than 13 years of experience in health care and pharmacy benefits consulting.
Visit http://aishealth.com/marketplace/c2p21_042412 for more details and registration information.
AIS develops highly targeted news, data and strategies for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. Learn more at http://www.AISHealth.com.